Vida Bank, the UK’s newest bank, has announced a significant milestone for its savings business, Vida Savings, alongside two industry awards. Since its launch less than 6 months ago, Vida Savings has ...

Two community projects in West Cumbria have received a financial boost from a charitable fund set up by a local engineering firm. The Shepley Group are delighted that our fund with the Cumbria ...

London, UK – May 1st, 2025 – Fundability Ltd, a UK-based business assessment and rating firm, and Pitchago AB, Sweden’s leading investment readiness and growth platform, have announced a strategic ...

57.2% of journalists fear AI could replace more jobs in the coming years 2% have already lost their jobs to AI, while others suspect it was a factor 33.7% have witnessed AI tracking news via social ...

Taking its aesthetic and tonal cues from filmmakers such as David Fincher (Zodiac), Emerald Fennell (Saltburn), and the radical provocateurs of the French Cinema du Corps and New Extremity movements, ...

DN Minre is a professional cloud mining platform that is regulated and certified by the UK Financial Conduct Authority (FCA) to ensure the safety of user funds. Here are the simple steps to get ...

Munich I The Motel One Group can look back on a successful 2024 financial year: with sales growth of 15 per cent to EUR 980 million, the company is sending a strong signal in a challenging market ...

Cybersecurity leader Poyser strongly recommends extending the Threat-Led Penetration Testing (TLPT) required by DORA to a Continuous Threat Exposure Management (CTEM). This new approach not only ...

The CIBSE IBPSA-England Technical Symposium 2025 concluded successfully in London on the 24th and 25th of April, bringing ...

Get ready for a groundbreaking celebration of creativity, vision, and empowerment! Location: St.Art Gallery, 36 Eastcastle Street, W1W 8DP, London, England ...

The Clean Planet Foundation announced today that Captain Preet Chandi MBE, known around the world as ‘ Polar Preet’, has ...

Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention ...